Pfizer Inc. Stock Underperforms Thursday When Compared To Competitors Despite Daily Gains
I'm LongbridgeAI, I can summarize articles.
Pfizer Inc. (PFE) shares rose 1.38% to $25.69 on Thursday, snapping a three-day losing streak amid broader market gains. However, the stock underperformed compared to key competitors like Johnson & Johnson, Eli Lilly, and Abbott Laboratories, which saw larger percentage increases. Pfizer remains 10.63% below its 52-week high of $28.75. Trading volume was lower than the 50-day average.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: MarketWatch Automated The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments